Squarepoint
SGRY icon

Squarepoint’s Surgery Partners SGRY Stock Holding History

Squarepoint’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,265
Closed -$352K – 4824
2025
Q3 		$352K Sell
16,265
-36,801
-69% -$821K ﹤0.01% 3544
2025
Q2 		$1.18M Sell
53,066
-154,971
-74% -$3.44M ﹤0.01% 2520
2025
Q1 		$4.94M Buy
+208,037
New +$4.92M 0.01% 1429
2024
Q2 		– Sell
-39,406
Closed -$1.18M – 4587
2024
Q1 		$1.18M Buy
39,406
+20,785
+112% +$650K ﹤0.01% 2480
2023
Q4 		$596K Sell
18,621
-17,185
-48% -$499K ﹤0.01% 2878
2023
Q3 		$1.05M Buy
+35,806
New +$1.29M ﹤0.01% 2289
2022
Q4 		– Sell
-55,244
Closed -$1.29M – 3555
2022
Q3 		$1.29M Buy
55,244
+47,327
+598% +$1.51M 0.01% 1588
2022
Q2 		$229K Buy
+7,917
New +$346K ﹤0.01% 2402
2022
Q1 		– Sell
-9,491
Closed -$507K – 3445
2021
Q4 		$507K Buy
9,491
+4,548
+92% +$211K ﹤0.01% 2133
2021
Q3 		$209K Buy
4,943
+390
+9% +$19.9K ﹤0.01% 2467
2021
Q2 		$303K Sell
4,553
-20,257
-82% -$1.1M ﹤0.01% 2524
2021
Q1 		$1.1M Buy
+24,810
New +$921K 0.01% 1434
2020
Q4 		– Sell
-35,611
Closed -$780K – 3224
2020
Q3 		$780K Buy
35,611
+4,900
+16% +$87.1K 0.01% 1134
2020
Q2 		$355K Buy
+30,711
New +$337K 0.01% 1501
2020
Q1 		– Sell
-17,200
Closed -$269K – 2439
2019
Q4 		$269K Sell
17,200
-78,558
-82% -$891K ﹤0.01% 2094
2019
Q3 		$707K Buy
95,758
+46,891
+96% +$336K 0.01% 1434
2019
Q2 		$398K Buy
+48,867
New +$487K ﹤0.01% 1790
2019
Q1 		– Sell
-70,405
Closed -$689K – 2405
2018
Q4 		$689K Buy
70,405
+50,620
+256% +$679K 0.01% 1079
2018
Q3 		$326K Buy
+19,785
New +$316K ﹤0.01% 1494
2018
Q1 		– Sell
-22,681
Closed -$274K – 2098
2017
Q4 		$274K Sell
22,681
-8,783
-28% -$84K ﹤0.01% 1574
2017
Q3 		$326K Buy
+31,464
New +$450K 0.01% 1139

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Squarepoint's SGRY Position: Q4 2025 in Review

Squarepoint sold out of Surgery Partners (SGRY) in Q4 2025, closing a stake of 16,265 shares — an estimated $352K sold.

Squarepoint first reported a position in SGRY in Q3 2017 and held it in 21 quarters. The position peaked at $4.94M in Q1 2025. 180 funds tracked by Wall St. Rank hold SGRY as of Q4 2025.

  • Squarepoint reported no remaining Surgery Partners position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 16,265 Surgery Partners shares in Q4 2025, an estimated $352K.
  • Squarepoint first reported a position in Surgery Partners in Q3 2017 and held it in 21 quarters.
  • Squarepoint's Surgery Partners position peaked at $4.94M in Q1 2025.
  • 180 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.